Investors

Recent Event

22nd Annual Rodman & Renshaw Global Investment Conference

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services with some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute.

Investor Contact Information

Company

Cancer Genetics, Inc.
201 Route 17 North
2nd Floor
Rutherford, NJ 07070
T: 201-528-9200

Investor Relations

Zimmons International Communications
Jennifer K. Zimmons, Ph.D.
President
T: 917-214-3514
jzimmons@zimmonsic.com

Transfer Agent

Continental Stock Transfer & Trust Company
Monty Harry, Senior Account Manager
17 Battery Place
8th Floor
New York, NY 10004
T: 212-845-3277
F: 212-616-7615
mharry@continentalstock.com